Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas
Authors
Keywords
PARP, Trabectedin, Sarcomas, Synergy
Journal
Journal of Hematology & Oncology
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-11
DOI
10.1186/s13045-017-0451-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
- (2016) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients
- (2015) A Laroche-Clary et al. BRITISH JOURNAL OF CANCER
- RG7112, a Small-Molecule Inhibitor of MDM2, Enhances Trabectedin Response in Soft Tissue Sarcomas
- (2015) Antònia Obrador-Hevia et al. CANCER INVESTIGATION
- Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma
- (2015) A M Puzio-Kuter et al. CELL DEATH AND DIFFERENTIATION
- Synergistic Effect of Trabectedin and Olaparib Combination Regimen in Breast Cancer Cell Lines
- (2015) Sonia Ávila-Arroyo et al. Journal of Breast Cancer
- Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study
- (2015) Akira Kawai et al. LANCET ONCOLOGY
- The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
- (2015) José Luis Ordóñez et al. Oncotarget
- The role of PARP in DNA repair and its therapeutic exploitation
- (2011) M Javle et al. BRITISH JOURNAL OF CANCER
- ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma
- (2011) Antoine Italiano et al. CANCER
- Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: A retrospective multicentric study
- (2011) P. Schöffski et al. EUROPEAN JOURNAL OF CANCER
- Trends in survival for patients with metastatic soft-tissue sarcoma
- (2010) Antoine Italiano et al. CANCER
- ATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 Inhibitors
- (2010) C. T. Williamson et al. MOLECULAR CANCER THERAPEUTICS
- Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis
- (2010) Mary Ellen Moynahan et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A Role for BRCA1 in Uterine Leiomyosarcoma
- (2009) D. Xing et al. CANCER RESEARCH
- Synthetic lethal targeting ofPTENmutant cells with PARP inhibitors
- (2009) Ana M. Mendes-Pereira et al. EMBO Molecular Medicine
- Common genetic changes in leiomyosarcoma and gastrointestinal stromal tumour: implication for ataxia telangiectasia mutated involvement
- (2009) Aliya Ul-Hassan et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- BRCA1 and its toolbox for the maintenance of genome integrity
- (2009) Michael S.Y. Huen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- DNA Damage, Aging, and Cancer
- (2009) Jan H.J. Hoeijmakers NEW ENGLAND JOURNAL OF MEDICINE
- Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors
- (2008) R. Plummer et al. CLINICAL CANCER RESEARCH
- Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers
- (2008) E. V. Stevens et al. MOLECULAR CANCER THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started